ZEAL:CPH
Zealand Pharma A/S
DKK 231.30
arrow_downward
-1.49%(-3.50) 1D
Oct 13, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKK 236.00
High
DKK 237.00
Low
DKK 228.60
Mkt. cap
16.81B
Avg. vol.
423.08K
Volume
283.74K
52-wk high
DKK 556.00
52-wk low
DKK 228.60
Shares outstanding
71.61M
No. of employees
578
Open
DKK 236.00
High
DKK 237.00
Low
DKK 228.60
Mkt. cap
16.81B
Avg. vol.
423.08K
Volume
283.74K
52-wk high
DKK 556.00
52-wk low
DKK 228.60
Shares outstanding
71.61M
No. of employees
578
News stories
From web sources and news partners
ChartMill
·
1 hour ago
Discover which dow jones stocks are making waves on Tuesday.
The Economic Times
·
11 minutes ago
Could the US stock market crash in October? What are the Dow Jones, S&P 500 and Nasdaq showing? Here’s wha
Barron's
·
1 hour ago
The AI Trade Led the Bull Market—but Don’t Bail on the Big Winners Just Yet
The Motley Fool
·
1 hour ago
Tech Stocks Are Crushing the Market, but There's a Sneaky (and Dangerous) Risk for S&P 500 Investors
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com